TRENDING :  Market Movers  |  Top 50   FDX (-1.54%)    AMZN (-2.01%)    SPY (-1.22%)    SQ (-3.65%)    TAC (-0.74%)    TARO (0.45%)    TJX (0.17%)    TSLA (-2.59%)    UNIT (-2.11%)    UTX (-0.81%)    VXXB (6.43%)    WYNN (-2.74%)    XLU (1.24%)    XPER (-3.91%)    XRX (-4.35%)    ZUO (-10.65%)    BA (-1.78%)    BAC (-3.94%)    BIIB (-3.02%)    BPTH (22.3%)    BRS (-3.07%)    CFMS (-0.42%)    CLRB (-4.07%)    CVRS (4.62%)    CZZ (-7.3%)

 NBY - NovaBay Pharmaceuticals

$1.40 [0.07][5.27%]

Next Earnings

3/25/2019

AMC

Recommend
Trade Idea »



OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $NBY

Service NameTrader% Success
AungPan Thar's Swing tradingKyaw Aung74.00 %Subscribe

TRENDING ARTICLES



NovaBay Pharmaceuticals Cuts Jobs in US in Avenova Sales Shift, Names Chairman, New Interim President and CEO and New Interim CFO

03/12/19
NovaBay Pharmaceuticals NBY said it is cutting jobs in the US as part of a strategic sales shift for Avenova NovaBay Pharmaceuticals NBY said it is cutting jobs in the US as part of a strategic sales shift for Avenova It said it will deploy its sales representatives only

Analysts Estimate NovaBay Pharmaceuticals (NBY) to Report a Decline in Earnings: What to Look Out for

03/12/19
The market expects NovaBay Pharmaceuticals NBY to deliver a year over year decline in earnings on lower revenues when i t report s results for the quarter ended December 2018 This widely known consensus outlook is important in assessing the company s earnings picture but a powerful factor